Bessemer Group Inc. Sells 61,181 Shares of Kenvue Inc. (NYSE:KVUE)

Bessemer Group Inc. lowered its stake in shares of Kenvue Inc. (NYSE:KVUE - Free Report) by 2.4% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,441,098 shares of the company's stock after selling 61,181 shares during the period. Bessemer Group Inc. owned 0.13% of Kenvue worth $52,117,000 at the end of the most recent quarter.

Several other large investors also recently made changes to their positions in the stock. Handelsbanken Fonder AB boosted its holdings in Kenvue by 2.9% in the 4th quarter. Handelsbanken Fonder AB now owns 742,184 shares of the company's stock valued at $15,846,000 after purchasing an additional 21,222 shares during the period. Alberta Investment Management Corp grew its holdings in shares of Kenvue by 23.2% during the 4th quarter. Alberta Investment Management Corp now owns 582,895 shares of the company's stock worth $12,445,000 after purchasing an additional 109,700 shares in the last quarter. Longbow Finance SA increased its position in shares of Kenvue by 5.0% in the fourth quarter. Longbow Finance SA now owns 280,568 shares of the company's stock worth $5,990,000 after purchasing an additional 13,287 shares during the period. Steward Partners Investment Advisory LLC raised its stake in Kenvue by 143.1% in the fourth quarter. Steward Partners Investment Advisory LLC now owns 47,938 shares of the company's stock valued at $1,023,000 after purchasing an additional 28,216 shares in the last quarter. Finally, CORDA Investment Management LLC. raised its stake in Kenvue by 1.4% in the fourth quarter. CORDA Investment Management LLC. now owns 1,253,096 shares of the company's stock valued at $26,754,000 after purchasing an additional 17,466 shares in the last quarter. Institutional investors and hedge funds own 97.64% of the company's stock.

Remove Ads

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on KVUE shares. Piper Sandler upped their price target on shares of Kenvue from $24.00 to $27.00 and gave the stock an "overweight" rating in a report on Monday, February 24th. Evercore ISI started coverage on Kenvue in a research report on Monday, March 24th. They set an "in-line" rating and a $25.00 price objective for the company. Canaccord Genuity Group lifted their target price on Kenvue from $24.00 to $29.00 and gave the company a "buy" rating in a research report on Wednesday, March 5th. Barclays dropped their target price on shares of Kenvue from $23.00 to $22.00 and set an "equal weight" rating for the company in a report on Monday. Finally, Citigroup boosted their target price on shares of Kenvue from $21.00 to $22.00 and gave the stock a "neutral" rating in a research note on Monday. Eight equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus target price of $24.42.

Kenvue Trading Up 0.7 %

NYSE:KVUE traded up $0.15 on Tuesday, reaching $22.86. 6,596,689 shares of the stock traded hands, compared to its average volume of 16,877,238. The company has a current ratio of 1.00, a quick ratio of 0.69 and a debt-to-equity ratio of 0.66. Kenvue Inc. has a 1-year low of $17.67 and a 1-year high of $24.46. The company's 50 day moving average is $22.69 and its 200-day moving average is $22.40. The firm has a market capitalization of $43.69 billion, a price-to-earnings ratio of 43.13, a price-to-earnings-growth ratio of 2.62 and a beta of 1.02.

Kenvue (NYSE:KVUE - Get Free Report) last posted its quarterly earnings data on Thursday, February 6th. The company reported $0.26 earnings per share for the quarter, hitting the consensus estimate of $0.26. Kenvue had a net margin of 6.66% and a return on equity of 20.97%. Equities research analysts anticipate that Kenvue Inc. will post 1.14 EPS for the current fiscal year.

Kenvue Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Wednesday, February 26th. Shareholders of record on Wednesday, February 12th were issued a $0.205 dividend. The ex-dividend date of this dividend was Wednesday, February 12th. This represents a $0.82 dividend on an annualized basis and a yield of 3.59%. Kenvue's payout ratio is currently 154.72%.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.